Enucleation of keratocystic odontogenic tumours: study interpretation, technical refinement and future research.
Pitak-Arnnop
Poramate
P
D019342:Acetic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002424:Caustics / Q000009:adverse effects; D002725:Chloroform / Q000009:adverse effects / Q000627:therapeutic use*; D000431:Ethanol / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007573:Jaw Neoplasms / Q000188:drug therapy / Q000601:surgery*; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D009808:Odontogenic Tumors / Q000188:drug therapy / Q000601:surgery*; D012107:Research Design; D018401:Sample Size
D000970:Antineoplastic Agents; C033474:Carnoy's solution; D002424:Caustics; D000431:Ethanol; D002725:Chloroform; D019342:Acetic Acid